Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program

Clinical Infectious Diseases, Volume 64, No. 5, Year 2017

Patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV coinfected patients participating in an Italian compassionate-use program of ombitasvir/ paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV).

Statistics
Citations: 31
Authors: 31
Affiliations: 26
Identifiers
Doi: 10.1093/cid/ciw846
ISSN: 10584838
e-ISSN: 15376591
Research Areas
Infectious Diseases

Disclaimer

All information and calculations provided are based on our current indexed publications and may change as more data is collected.

African Research Nexus

The African Research Nexus is a visionary initiative that seeks to increase the visibility of African Researchers and Institutions. We are a dynamic hub designed to transform the African research landscape and amplify the voices of our continent’s brightest minds.

Useful Links

ABOUT US
PROFILES
Authors Directory
AI Digest
CONTACT US

Subscribe Now
Don’t miss our future updates!

Follow Us